Lavinia Țocu

Lavinia Țocu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
GȚGeorge Țocu
George Țocu
BSBogdan Ioan Stefanescu
Bogdan Ioan Stefanescu
LMLoredana Matei
Loredana Matei
LȚLavinia Țocu
Lavinia Țocu
ROS derived from NADPH oxidase, particularly NOX2, are central to antimicrobial defense, coupling direct pathogen killing with redox signaling that shapes inflammation. This narrative review integrates recent advances on NOX2 structure, assembly, and spatiotemporal control in phagocytes, and outlines how ROS interact with NF-κB, MAPK, and Nrf2 networks to coordinate microbicidal activity and immune modulation. We summarize evidence that both ROS deficiency, as in chronic granulomatous disease, and uncontrolled excess, as in sepsis and severe COVID-19, drive clinically significant pathology, emphasizing the need for precise redox balance. Emerging therapeutic strategies include selective NOX2 inhibitors that limit pathological oxidative bursts, redox-modulating peptides that disrupt upstream activation cues, and Nrf2 activators that enhance endogenous antioxidant capacity, with attention to dosing challenges that preserve host defense while mitigating tissue injury. Key gaps remain in biomarker standardization, real-time in vivo ROS monitoring, and translation from animal models to patients, motivating personalized, combination approaches to redox medicine in infectious diseases.

13 May 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
GȚGeorge Țocu
George Țocu
BSBogdan Ioan Stefanescu
Bogdan Ioan Stefanescu
LȚLavinia Țocu
Lavinia Țocu
FDFlorentin Dimofte
Florentin Dimofte
VLValerii Lutenco
Valerii Lutenco
RMRaul Mihailov
Raul Mihailov
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in which dopaminergic dysfunction plays a central role. Beyond its neurotransmitter function, dopamine is a redox-active molecule capable of generating reactive oxygen species and toxic intermediates, particularly when cytosolic dopamine accumulates because of altered vesicular storage or transporter imbalance. This review examines whether dopamine-derived oxidative stress may represent a biologically plausible and testable framework for ADHD by integrating current evidence on dopamine metabolism, oxidative stress, and neuronal dysfunction, while distinguishing direct evidence from indirect and translational findings. A structured literature search was conducted in PubMed, Scopus, and Web of Science for relevant English-language studies published between January 2000 and March 2026. The available evidence suggests that dopamine-derived oxidative stress may help link disturbed dopamine handling to protein modification, lipid peroxidation, mitochondrial dysfunction, synaptic inefficiency, and circuit-level abnormalities in ADHD. Although direct in vivo evidence remains limited, this framework may help distinguish dopamine-derived oxidative stress from more general oxidative imbalance in ADHD and may guide future biomarker-based, experimental, and translational research.

2 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
GȚGeorge Țocu
George Țocu
BSBogdan Ioan Stefanescu
Bogdan Ioan Stefanescu
LȚLavinia Țocu
Lavinia Țocu
FDFlorentin Dimofte
Florentin Dimofte
VLValerii Lutenco
Valerii Lutenco
LMLoredana Matei
Loredana Matei
Background: Short-term mortality stratification in sepsis remains clinically challenging, particularly because outcome is influenced by acute inflammation, coagulation abnormalities, organ dysfunction, and baseline comorbidity burden. This study evaluated the clinical performance of the BIO-S and BIO-SC composite bioscores for 28-day mortality stratification in adults with sepsis and septic shock. Methods: We conducted a prospective observational monocentric cohort study including 572 adult patients admitted between January 2022 and December 2024. BIO-S integrated procalcitonin (PCT), neutrophil-to-lymphocyte ratio (NLR), International Normalized Ratio (INR), and Sequential Organ Failure Assessment (SOFA) score, while BIO-SC extended this model by adding the Charlson Comorbidity Index (CCI). Prognostic performance was assessed using receiver operating characteristic (ROC) curve analysis, DeLong comparisons, bootstrap validation, calibration analysis, Kaplan–Meier survival curves, and Cox proportional hazards models. Results: The cohort included 418 patients with sepsis and 154 patients with septic shock. Overall 28-day mortality was 31.5% and was significantly higher in septic shock than in sepsis, 77.9% versus 14.4%, p < 0.001. BIO-S and BIO-SC showed strong discriminatory ability for 28-day mortality, with areas under the curve (AUCs) of 0.889 and 0.897, respectively. BIO-SC had the highest AUC, although the difference between BIO-SC and BIO-S was not statistically significant by the DeLong test, p = 0.328. At the optimal thresholds, BIO-S showed 97.8% sensitivity and 69.4% specificity, while BIO-SC showed 89.4% sensitivity and 77.8% specificity. Both bioscores stratified observed mortality across predefined risk categories and remained significantly associated with 28-day mortality in adjusted Cox models. Conclusions: BIO-S and BIO-SC showed clinically relevant performance for 28-day mortality stratification in adults with sepsis and septic shock. BIO-SC provided a numerically higher AUC and slightly better calibration, suggesting that comorbidity burden may improve prognostic characterization, although further independent multicenter validation is needed before broader clinical implementation.

4 November 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
LȚLavinia Țocu
Lavinia Țocu
BSBogdan Ioan Stefanescu
Bogdan Ioan Stefanescu
RMRaul Mihailov
Raul Mihailov
VLValerii Lutenco
Valerii Lutenco
OMOana Mariana Mihailov
Oana Mariana Mihailov
GȚGeorge Țocu
George Țocu
Myocardial infarction (MI) remains a major cause of death and heart failure despite reperfusion. Reopening an occluded coronary artery salvages viable myocardium but creates an ischemia–reperfusion environment in which reactive oxygen species (ROS) and reactive nitrogen species (RNS) can contribute to injury. Postinfarction redox responses continue through inflammation, repair, and remodeling. Their effects depend on species, concentration, source, compartment, timing, molecular targets, and local antioxidant capacity; controlled redox signaling is essential for normal vascular, metabolic, and immune function. This narrative review focuses primarily on type 1 MI, particularly reperfused ST-segment elevation MI. It examines mitochondrial and enzymatic oxidant sources, including nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, xanthine oxidoreductase, nitric oxide synthases, and myeloperoxidase, alongside secondary lipid- and nitrogen-derived products. It considers their roles in microvascular dysfunction, cardiomyocyte injury and death, inflammatory amplification, fibrosis, ventricular dysfunction, heart failure, and arrhythmic vulnerability. Circulating oxidative-stress biomarkers may be associated with infarct severity or later outcomes, but generally provide indirect information and have limited validation for clinical decision-making. Broad antioxidant strategies have not yielded consistent clinical benefit. More precise therapeutic approaches require source- and compartment-specific targeting, appropriate timing and patient selection, reliable measures of target engagement, and benefit beyond contemporary MI care.

20 October 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
GȚGeorge Țocu
George Țocu
BSBogdan Ioan Stefanescu
Bogdan Ioan Stefanescu
CPCatalin Plesea-Condratovici
Catalin Plesea-Condratovici
VLValerii Lutenco
Valerii Lutenco
LMLoredana Matei
Loredana Matei
EMElena Mocanu
Elena Mocanu
Spleen tyrosine kinase is a non-receptor tyrosine kinase that couples receptor engagement to cellular survival, immune responses, and tissue injury. This narrative review compares its biology in malignancies and sepsis to examine how cellular compartment, receptor architecture, activation state, and signaling duration alter the meaning of a common signaling hub. A structured narrative search of PubMed/MEDLINE, Scopus, and Web of Science covered English-language publications from January 2000 to August 2026, supplemented by older seminal studies. In several hematological malignancies, sustained receptor signaling or oncogenic cooperation supports malignant-cell persistence; solid tumors show both tumor-promoting and tumor-suppressive functions. In sepsis, dynamically changing immune and vascular responses link spleen tyrosine kinase to pathogen recognition, inflammatory and oxidative responses, endothelial dysfunction, and organ injury. Oncology includes mechanistic studies, human cohorts, and early clinical therapeutic trials, whereas sepsis evidence remains predominantly experimental, with limited human observational and ex vivo validation. Transcript abundance, total protein, and phosphorylation are distinct biomarker endpoints whose interpretation requires identification of the cellular source and sampling context. Kinase inhibitors have shown clinical activity in selected malignancies and protection in experimental sepsis, but these findings do not establish a validated predictive biomarker or clinical efficacy in sepsis. Translation requires disease-specific validation, standardized cellular assessment, and attention to treatment timing and preservation of host defense.

18 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LMLoredana Matei
Loredana Matei
LȚLavinia Țocu
Lavinia Țocu
ANAurel Nechita
Aurel Nechita
LNLuiza Camelia Nechita
Luiza Camelia Nechita
OMOana Mariana Mihailov
Oana Mariana Mihailov
GȚGeorge Țocu
George Țocu
Background: Non-pharmaceutical interventions during the COVID-19 pandemic altered respiratory pathogen circulation, and a bacterial rebound followed once restrictions were lifted. We describe pediatric pneumococcal respiratory infections and their bacterial co-detections in the immediate post-pandemic period. Methods: We retrospectively analyzed respiratory specimens from children aged 0–18 years tested with a multiplex real-time PCR panel (Allplex Respiratory Panel, Seegene, Seoul, South Korea; seven bacterial pathogens) restricted to this predefined bacterial spectrum at a tertiary pediatric hospital in Galați, Romania, during 2022 and 2023. A total of 2546 panels were performed in 2022 and 3250 in 2023, allowing pneumococcal positivity rates to be calculated. Proportions are reported with Wilson 95% confidence intervals; associations were tested with Pearson chi-square and Fisher exact tests in SPSS v.23. Results: Children with detected Streptococcus pneumoniae rose from 100 to 415, corresponding to a rise in pneumococcal positivity from 3.9% (100/2546) to 12.8% (415/3250). Among the positive children, pneumococcus–Haemophilus influenzae co-detection increased from 33.0% to 45.1% (odds ratio 1.63, 95% CI 1.02–2.61; p = 0.029), while pneumococcus alone fell from 60.0% to 50.1%. Boys, urban residence, and early childhood predominated, and community-acquired pneumonia diagnoses rose from 61 to 214. No profile–demographic association reached significance (panel–residence 2023, p = 0.063). Conclusions: A post-pandemic rise in pediatric pneumococcal detections and increasing H. influenzae co-detection were observed, supporting syndromic multiplex PCR in rapid pediatric diagnostics and antimicrobial stewardship.